Medical Care

Global Diagnosis of Autoimmune Diseases Market Research Report 2025

The global market for Diagnosis of Autoimmune Diseases was valued at US$ 1284 million in the year 2024 and is projected to reach a revised size of US$ 2009 million by 2031, growing at a CAGR of 6.7% during the forecast period.
The diagnosis of autoimmune diseases refers to the process of identifying and confirming the presence of an autoimmune condition in an individual. This process typically involves a comprehensive evaluation of the individual’s medical history, a physical examination, and various laboratory tests aimed at detecting specific antibodies, inflammation markers, and other indicators of an autoimmune response within the body. Additionally, imaging tests and, in some cases, tissue biopsies may be utilized to provide further insight into the presence and potential impact of the autoimmune disease on the affected organs or tissues.
Overall, the diagnosis of autoimmune diseases is a complex and often multidisciplinary endeavor that aims to accurately identify the specific autoimmune condition affecting an individual, thereby facilitating the development of an appropriate treatment plan and management strategy.
The global market for the diagnosis of autoimmune diseases encompasses a wide range of diagnostic technologies, tests, and tools used for identifying and monitoring various autoimmune conditions. This market includes but is not limited to laboratory-based tests such as blood tests, autoantibody assays, and biomarker analysis, as well as imaging techniques like MRI, CT scans, and ultrasound that are utilized in the diagnosis and monitoring of autoimmune diseases.
The market for autoimmune disease diagnosis is shaped by ongoing technological advancements, the development of innovative diagnostic tools, and an increasing focus on personalized and precision medicine approaches. Additionally, the growing prevalence of autoimmune diseases worldwide has contributed to the expansion of the diagnostic market.
The market is also influenced by the rising awareness about early diagnosis and treatment of autoimmune diseases, as well as the increasing efforts to improve the efficiency and accuracy of diagnostic tools. Furthermore, the integration of novel technologies such as artificial intelligence, molecular diagnostics, and point-of-care testing is likely to drive growth and innovation within the autoimmune disease diagnostics market.
This report aims to provide a comprehensive presentation of the global market for Diagnosis of Autoimmune Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnosis of Autoimmune Diseases.
The Diagnosis of Autoimmune Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnosis of Autoimmune Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnosis of Autoimmune Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Siemens
Inova Diagnostics
GRIFOLS
Danaher
Bio-Rad Laboratories
Abbott
Trinity Biotech
Werfen
Protagen
HYCOR Biomedical
HTG Molecular Diagnostics
EUROIMMUN AG
Segment by Type
Routine Laboratory Tests
Inflammatory Markers
Autoantibodies & Immunologic Test
Other
Segment by Application
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Sjögren’s Syndrome
Thyroiditis
Scleroderma
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diagnosis of Autoimmune Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnosis of Autoimmune Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Routine Laboratory Tests
1.2.3 Inflammatory Markers
1.2.4 Autoantibodies & Immunologic Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Diagnosis of Autoimmune Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Rheumatoid Arthritis
1.3.3 Systemic Lupus Erythematosus
1.3.4 Sjögren’s Syndrome
1.3.5 Thyroiditis
1.3.6 Scleroderma
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnosis of Autoimmune Diseases Market Perspective (2020-2031)
2.2 Global Diagnosis of Autoimmune Diseases Growth Trends by Region
2.2.1 Global Diagnosis of Autoimmune Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diagnosis of Autoimmune Diseases Historic Market Size by Region (2020-2025)
2.2.3 Diagnosis of Autoimmune Diseases Forecasted Market Size by Region (2026-2031)
2.3 Diagnosis of Autoimmune Diseases Market Dynamics
2.3.1 Diagnosis of Autoimmune Diseases Industry Trends
2.3.2 Diagnosis of Autoimmune Diseases Market Drivers
2.3.3 Diagnosis of Autoimmune Diseases Market Challenges
2.3.4 Diagnosis of Autoimmune Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diagnosis of Autoimmune Diseases Players by Revenue
3.1.1 Global Top Diagnosis of Autoimmune Diseases Players by Revenue (2020-2025)
3.1.2 Global Diagnosis of Autoimmune Diseases Revenue Market Share by Players (2020-2025)
3.2 Global Diagnosis of Autoimmune Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diagnosis of Autoimmune Diseases Revenue
3.4 Global Diagnosis of Autoimmune Diseases Market Concentration Ratio
3.4.1 Global Diagnosis of Autoimmune Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnosis of Autoimmune Diseases Revenue in 2024
3.5 Global Key Players of Diagnosis of Autoimmune Diseases Head office and Area Served
3.6 Global Key Players of Diagnosis of Autoimmune Diseases, Product and Application
3.7 Global Key Players of Diagnosis of Autoimmune Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnosis of Autoimmune Diseases Breakdown Data by Type
4.1 Global Diagnosis of Autoimmune Diseases Historic Market Size by Type (2020-2025)
4.2 Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Type (2026-2031)
5 Diagnosis of Autoimmune Diseases Breakdown Data by Application
5.1 Global Diagnosis of Autoimmune Diseases Historic Market Size by Application (2020-2025)
5.2 Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diagnosis of Autoimmune Diseases Market Size (2020-2031)
6.2 North America Diagnosis of Autoimmune Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diagnosis of Autoimmune Diseases Market Size by Country (2020-2025)
6.4 North America Diagnosis of Autoimmune Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diagnosis of Autoimmune Diseases Market Size (2020-2031)
7.2 Europe Diagnosis of Autoimmune Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diagnosis of Autoimmune Diseases Market Size by Country (2020-2025)
7.4 Europe Diagnosis of Autoimmune Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size (2020-2031)
8.2 Asia-Pacific Diagnosis of Autoimmune Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diagnosis of Autoimmune Diseases Market Size (2020-2031)
9.2 Latin America Diagnosis of Autoimmune Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2020-2025)
9.4 Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size (2020-2031)
10.2 Middle East & Africa Diagnosis of Autoimmune Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Introduction
11.1.4 Thermo Fisher Scientific Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Diagnosis of Autoimmune Diseases Introduction
11.2.4 Siemens Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.2.5 Siemens Recent Development
11.3 Inova Diagnostics
11.3.1 Inova Diagnostics Company Details
11.3.2 Inova Diagnostics Business Overview
11.3.3 Inova Diagnostics Diagnosis of Autoimmune Diseases Introduction
11.3.4 Inova Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.3.5 Inova Diagnostics Recent Development
11.4 GRIFOLS
11.4.1 GRIFOLS Company Details
11.4.2 GRIFOLS Business Overview
11.4.3 GRIFOLS Diagnosis of Autoimmune Diseases Introduction
11.4.4 GRIFOLS Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.4.5 GRIFOLS Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher Diagnosis of Autoimmune Diseases Introduction
11.5.4 Danaher Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.5.5 Danaher Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Introduction
11.6.4 Bio-Rad Laboratories Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Diagnosis of Autoimmune Diseases Introduction
11.7.4 Abbott Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.7.5 Abbott Recent Development
11.8 Trinity Biotech
11.8.1 Trinity Biotech Company Details
11.8.2 Trinity Biotech Business Overview
11.8.3 Trinity Biotech Diagnosis of Autoimmune Diseases Introduction
11.8.4 Trinity Biotech Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.8.5 Trinity Biotech Recent Development
11.9 Werfen
11.9.1 Werfen Company Details
11.9.2 Werfen Business Overview
11.9.3 Werfen Diagnosis of Autoimmune Diseases Introduction
11.9.4 Werfen Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.9.5 Werfen Recent Development
11.10 Protagen
11.10.1 Protagen Company Details
11.10.2 Protagen Business Overview
11.10.3 Protagen Diagnosis of Autoimmune Diseases Introduction
11.10.4 Protagen Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.10.5 Protagen Recent Development
11.11 HYCOR Biomedical
11.11.1 HYCOR Biomedical Company Details
11.11.2 HYCOR Biomedical Business Overview
11.11.3 HYCOR Biomedical Diagnosis of Autoimmune Diseases Introduction
11.11.4 HYCOR Biomedical Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.11.5 HYCOR Biomedical Recent Development
11.12 HTG Molecular Diagnostics
11.12.1 HTG Molecular Diagnostics Company Details
11.12.2 HTG Molecular Diagnostics Business Overview
11.12.3 HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Introduction
11.12.4 HTG Molecular Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.12.5 HTG Molecular Diagnostics Recent Development
11.13 EUROIMMUN AG
11.13.1 EUROIMMUN AG Company Details
11.13.2 EUROIMMUN AG Business Overview
11.13.3 EUROIMMUN AG Diagnosis of Autoimmune Diseases Introduction
11.13.4 EUROIMMUN AG Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025)
11.13.5 EUROIMMUN AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diagnosis of Autoimmune Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Routine Laboratory Tests
Table 3. Key Players of Inflammatory Markers
Table 4. Key Players of Autoantibodies & Immunologic Test
Table 5. Key Players of Other
Table 6. Global Diagnosis of Autoimmune Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Diagnosis of Autoimmune Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Diagnosis of Autoimmune Diseases Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Diagnosis of Autoimmune Diseases Market Share by Region (2020-2025)
Table 10. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Diagnosis of Autoimmune Diseases Market Share by Region (2026-2031)
Table 12. Diagnosis of Autoimmune Diseases Market Trends
Table 13. Diagnosis of Autoimmune Diseases Market Drivers
Table 14. Diagnosis of Autoimmune Diseases Market Challenges
Table 15. Diagnosis of Autoimmune Diseases Market Restraints
Table 16. Global Diagnosis of Autoimmune Diseases Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Diagnosis of Autoimmune Diseases Market Share by Players (2020-2025)
Table 18. Global Top Diagnosis of Autoimmune Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnosis of Autoimmune Diseases as of 2024)
Table 19. Ranking of Global Top Diagnosis of Autoimmune Diseases Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Diagnosis of Autoimmune Diseases Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Diagnosis of Autoimmune Diseases, Headquarters and Area Served
Table 22. Global Key Players of Diagnosis of Autoimmune Diseases, Product and Application
Table 23. Global Key Players of Diagnosis of Autoimmune Diseases, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diagnosis of Autoimmune Diseases Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2020-2025)
Table 27. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Type (2026-2031)
Table 29. Global Diagnosis of Autoimmune Diseases Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Application (2020-2025)
Table 31. Global Diagnosis of Autoimmune Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Diagnosis of Autoimmune Diseases Revenue Market Share by Application (2026-2031)
Table 33. North America Diagnosis of Autoimmune Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Diagnosis of Autoimmune Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Diagnosis of Autoimmune Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Diagnosis of Autoimmune Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Diagnosis of Autoimmune Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Diagnosis of Autoimmune Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Diagnosis of Autoimmune Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Diagnosis of Autoimmune Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 48. Thermo Fisher Scientific Company Details
Table 49. Thermo Fisher Scientific Business Overview
Table 50. Thermo Fisher Scientific Diagnosis of Autoimmune Diseases Product
Table 51. Thermo Fisher Scientific Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 52. Thermo Fisher Scientific Recent Development
Table 53. Siemens Company Details
Table 54. Siemens Business Overview
Table 55. Siemens Diagnosis of Autoimmune Diseases Product
Table 56. Siemens Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 57. Siemens Recent Development
Table 58. Inova Diagnostics Company Details
Table 59. Inova Diagnostics Business Overview
Table 60. Inova Diagnostics Diagnosis of Autoimmune Diseases Product
Table 61. Inova Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 62. Inova Diagnostics Recent Development
Table 63. GRIFOLS Company Details
Table 64. GRIFOLS Business Overview
Table 65. GRIFOLS Diagnosis of Autoimmune Diseases Product
Table 66. GRIFOLS Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 67. GRIFOLS Recent Development
Table 68. Danaher Company Details
Table 69. Danaher Business Overview
Table 70. Danaher Diagnosis of Autoimmune Diseases Product
Table 71. Danaher Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 72. Danaher Recent Development
Table 73. Bio-Rad Laboratories Company Details
Table 74. Bio-Rad Laboratories Business Overview
Table 75. Bio-Rad Laboratories Diagnosis of Autoimmune Diseases Product
Table 76. Bio-Rad Laboratories Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 77. Bio-Rad Laboratories Recent Development
Table 78. Abbott Company Details
Table 79. Abbott Business Overview
Table 80. Abbott Diagnosis of Autoimmune Diseases Product
Table 81. Abbott Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 82. Abbott Recent Development
Table 83. Trinity Biotech Company Details
Table 84. Trinity Biotech Business Overview
Table 85. Trinity Biotech Diagnosis of Autoimmune Diseases Product
Table 86. Trinity Biotech Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 87. Trinity Biotech Recent Development
Table 88. Werfen Company Details
Table 89. Werfen Business Overview
Table 90. Werfen Diagnosis of Autoimmune Diseases Product
Table 91. Werfen Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 92. Werfen Recent Development
Table 93. Protagen Company Details
Table 94. Protagen Business Overview
Table 95. Protagen Diagnosis of Autoimmune Diseases Product
Table 96. Protagen Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 97. Protagen Recent Development
Table 98. HYCOR Biomedical Company Details
Table 99. HYCOR Biomedical Business Overview
Table 100. HYCOR Biomedical Diagnosis of Autoimmune Diseases Product
Table 101. HYCOR Biomedical Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 102. HYCOR Biomedical Recent Development
Table 103. HTG Molecular Diagnostics Company Details
Table 104. HTG Molecular Diagnostics Business Overview
Table 105. HTG Molecular Diagnostics Diagnosis of Autoimmune Diseases Product
Table 106. HTG Molecular Diagnostics Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 107. HTG Molecular Diagnostics Recent Development
Table 108. EUROIMMUN AG Company Details
Table 109. EUROIMMUN AG Business Overview
Table 110. EUROIMMUN AG Diagnosis of Autoimmune Diseases Product
Table 111. EUROIMMUN AG Revenue in Diagnosis of Autoimmune Diseases Business (2020-2025) & (US$ Million)
Table 112. EUROIMMUN AG Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report


List of Figures
Figure 1. Diagnosis of Autoimmune Diseases Picture
Figure 2. Global Diagnosis of Autoimmune Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diagnosis of Autoimmune Diseases Market Share by Type: 2024 VS 2031
Figure 4. Routine Laboratory Tests Features
Figure 5. Inflammatory Markers Features
Figure 6. Autoantibodies & Immunologic Test Features
Figure 7. Other Features
Figure 8. Global Diagnosis of Autoimmune Diseases Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Diagnosis of Autoimmune Diseases Market Share by Application: 2024 VS 2031
Figure 10. Rheumatoid Arthritis Case Studies
Figure 11. Systemic Lupus Erythematosus Case Studies
Figure 12. Sjögren’s Syndrome Case Studies
Figure 13. Thyroiditis Case Studies
Figure 14. Scleroderma Case Studies
Figure 15. Other Case Studies
Figure 16. Diagnosis of Autoimmune Diseases Report Years Considered
Figure 17. Global Diagnosis of Autoimmune Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Diagnosis of Autoimmune Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Diagnosis of Autoimmune Diseases Market Share by Region: 2024 VS 2031
Figure 20. Global Diagnosis of Autoimmune Diseases Market Share by Players in 2024
Figure 21. Global Top Diagnosis of Autoimmune Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnosis of Autoimmune Diseases as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Diagnosis of Autoimmune Diseases Revenue in 2024
Figure 23. North America Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Diagnosis of Autoimmune Diseases Market Share by Country (2020-2031)
Figure 25. United States Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Diagnosis of Autoimmune Diseases Market Share by Country (2020-2031)
Figure 29. Germany Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Diagnosis of Autoimmune Diseases Market Share by Region (2020-2031)
Figure 37. China Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Diagnosis of Autoimmune Diseases Market Share by Country (2020-2031)
Figure 45. Mexico Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Diagnosis of Autoimmune Diseases Market Share by Country (2020-2031)
Figure 49. Turkey Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Diagnosis of Autoimmune Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 53. Siemens Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 54. Inova Diagnostics Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 55. GRIFOLS Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 56. Danaher Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 58. Abbott Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 59. Trinity Biotech Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 60. Werfen Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 61. Protagen Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 62. HYCOR Biomedical Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 63. HTG Molecular Diagnostics Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 64. EUROIMMUN AG Revenue Growth Rate in Diagnosis of Autoimmune Diseases Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies